Clinical Research Related Courses
Part of a STAR Programme

You want to understand the activities and specific requirements for the clinical development of a vaccine ? This course gives you the answers on the differences with pharmaceutical trials, identifies the challenges and let you understand the biological business.

We have updated the programme this year, to include a practical workshop on assessing risk/benefit ratio from the point of view of the regulator and the manufacturer.

This 2 day course highlights the highly demanding activities and specific requirements of regulatory characteristics – the quality, safety, efficacy and also clinical trial performance in the development of vaccines. We do have 3 exquisite trainers, all having vast experience in vaccine development.
The first part of the course describes the regulatory aspects of the development and marketing authorization of biological medicinal products. The second part focusses on all practical aspects of the performance of clinical trials with vaccines. Finally, the last part (on the second day) will include a workshop where participants will assess risk/benefit ratio from the point of view of the regulators and manufacturer.


Course time
Day 1: 08h30 - 17h30 Day 2: 08h30 - 12h00
Who should attend
  • Managers & scientists involved in clinical research with vaccines
  • Regulatory managers of biological medicinal products
  • Project Managers & Clinical Research Associates (CRAs) working with biological medicinal products
  • Professionals in these fields wishing to refresh their knowledge and skills
Programme highlights
  • “The
    value of vaccines for the individual and for the society”: Overview of the
    specific nature and potential impact of biological medicinal products and the
    various types of vaccines that may be developed 
  • Requirements for a pharmaceutical company to successfully achieve the
    development, licensing and marketing of vaccines
  • The
    characteristics of a vaccine trial in general and with specific examples –
    bridging with the specific nature of vaccines
  • Discussion
    on the future of vaccine trials and devices in vaccine trials, including
    organizational aspects of vaccine trials
  • Illustrations
    with recently performed vaccine trials
  • RIsk/benefit ratio assessment 
Learning Objectives
  • To explain the particularities of a vaccine trial compared to a drug trial and the types of participants, and organization of recruitment, in a vaccine trial
  • To understand the biologics business
  • To identify challenges and possible issues
  • To illustrate the theory with examples of recently conducted vaccine trials

Book a course

Date Lang Location
Proceeding your application may take up to 24 working hours. In case of question, contact
1 500,00 € excl. VAT (if applicable)


Patricia Martin Killias
June 2016
LimmaTech Biologics AG

The course was very interactive and we had the posibility to really discuss the topics with the speakers and bring our own examples.